Almost exactly 1 year after saying it would seek a buyer for its Lap-Band obesity device, Allergan (NYSE:AGN) said today that Apollo Endosurgery agreed to spend up to $110 million on Allergan’s obesity intervention business, which includes the Orbera intra-gastric balloon.
USGI Medical will enroll up to 350 patients in an FDA-approved clinical trial of the g-Cath EZ suture anchor delivery catheter, an incision-free bariatric surgery technology that has already been used on more than 2,000 patients, mostly in Europe.
Gastric bypass surgery creates a small pouch in the stomach and connects it directly to the small intestine. Why does it help type 2 diabetes? (Wikimedia Commons)
The Lexington, Mass.-based medical device company said in a regulatory filing that it’s drummed up $34.8 million from 13 unnamed investors.
The Lexington, Mass.-based medical device company said centers in Spain, Switzerland and 3 in Germany are now implanting the device, a gut liner designed to inhibit the uptake of nutrients from food.
When the New York Post broke the story this week that New Jersey governor and presidential hopeful Chris Christie had underwent weight loss surgery using the LAP-BAND in February some on Wall Street bemoaned the rotund politicians timing.
MASSDEVICE ON CALL — Researchers found more evidence that bariatric weight-loss surgery may help reverse Type II diabetes for obese patients.
In a study of more than 200 patients, 1 in 4 experienced total metabolic remission at 6 years and another 1 in 4 showed partial remission, according to a study released during the Prediabetes and Metabolic Syndrome 2013 Congress in Austria.
Satiety Inc. can put a 4-year personal injury lawsuit in its rearview mirror now that the case has been dismissed by a federal judge.
The plaintiff, Lucia Burgos, failed to prove that the Palo Alto, Calif.-based medical device company’s stomach stapling device violated the protocols of its investigational device exemption from the FDA.